VKH
TENX icon

Virtu KCG Holdings’s Tenax Therapeutics TENX Stock Holding History

Virtu KCG Holdings’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$63K Buy
+3
New +$49.9K ﹤0.01% 2534
2016
Q2 		– Hold
0
– -$21K – 3327
2016
Q1 		– Hold
0
– – – 2591

Other funds holding TENX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu KCG Holdings's TENX Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Tenax Therapeutics (TENX) in Q2 2017: 3 shares worth $63K. The stake represents ﹤0.01% of the portfolio and ranks #2534 among its holdings.

10 funds tracked by Wall St. Rank hold TENX as of Q2 2017.

  • Virtu KCG Holdings held 3 shares of Tenax Therapeutics worth $63K as of Q2 2017.
  • Tenax Therapeutics was a new Virtu KCG Holdings position in Q2 2017.
  • Tenax Therapeutics made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2534 holding.
  • 10 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.